SeQuent Scientific Ltd
NSE:SEQUENT

Watchlist Manager
SeQuent Scientific Ltd Logo
SeQuent Scientific Ltd
NSE:SEQUENT
Watchlist
Price: 201 INR -3.86% Market Closed
Market Cap: 50.8B INR

SEQUENT's latest stock split occurred on Feb 25, 2016

The company executed a 10-for-2 stock split, meaning that for every 2 shares held, investors received 10 new shares.

The adjusted shares began trading on Feb 25, 2016. This was the only stock split in SEQUENT's history.

Last Splits:
Feb 25, 2016
10-for-2
Pre-Split Price
N/A
Post-Split Price
178.14
Before
After
Last Splits:
Feb 25, 2016
10-for-2

SeQuent Scientific Ltd
Stock Splits History

SEQUENT Stock Splits Timeline
Feb 25, 2016
Feb 25, 2016
Split 10-for-2
x5
Pre-Split Price
N/A
Post-Split Price
178.14
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.143 0.143 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.4 8.4 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 7, 2026
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
1-for-10
/10
0.35 0.35 EUR N/A
Load More

SeQuent Scientific Ltd
Glance View

Market Cap
50.3B INR
Industry
Pharmaceuticals

SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.

SEQUENT Intrinsic Value
99.62 INR
Overvaluation 50%
Intrinsic Value
Price
Back to Top